Full Breakdown
Dr. Casey Means' Nomination as Surgeon General Under Scrutiny
2/26/2026, 8:23:09 AM
Confirmation Hearing Highlights Concerns Over Glyphosate
During her confirmation hearing on Wednesday, Dr. Casey Means, President Donald Trump's nominee for surgeon general, faced significant scrutiny regarding her stance on glyphosate, a widely used herbicide. Senator Ed Markey (D-Mass.) questioned Means about her previous comments linking glyphosate to cancer and how Trump's recent executive order promoting increased domestic production of the chemical might conflict with her beliefs. Means, a proponent of the Make America Healthy Again (MAHA) movement, expressed her concerns about the health impacts of glyphosate, stating, "We must as a country move away from using toxic inputs in our food supply." Markey highlighted the contradiction between her views and the executive order, emphasizing that the MAHA movement opposes such policies.
Background on Dr. Casey Means and MAHA
Dr. Casey Means, a Stanford-educated physician and wellness influencer, has aligned herself with Health Secretary Robert F. Kennedy Jr. and the MAHA agenda, which advocates for the removal of harmful additives from food and promotes healthier nutrition programs. Her confirmation as surgeon general would empower her to issue public health advisories and lead initiatives aimed at addressing chronic diseases through dietary and lifestyle changes. However, her lack of government experience and the inactive status of her medical license have raised questions about her qualifications for the role.
Financial Disclosures and Ethical Concerns
Means has co-founded Levels, a health tracking app, and has earned substantial income promoting various health products. An Associated Press investigation revealed that she sometimes failed to disclose her financial interests when recommending these products. In her ethics filing, Means pledged to resign from her position at Levels and divest from any stock options if confirmed. She also committed to avoiding any direct financial interests in entities listed on the FDA's prohibited holdings list.
Criticism from Former Surgeons General
The nomination has faced criticism from former surgeons general, including Dr. Rich Carmona, who expressed concerns about Means' qualifications in an op-ed. Dr. Jerome Adams, another former surgeon general, noted on social media that the role traditionally requires an active medical license, which Means currently lacks. These critiques underscore the challenges she faces in securing confirmation.
Official Statements and Responses
In response to the scrutiny, Means reiterated her commitment to promoting sustainable farming practices and protecting American consumers. She stated, "I think it's extremely important, both for our planet and our health, and I'm going to be a champion on that issue." However, the MAHA movement's discontent with the executive order remains a significant point of contention.
What's Next for Dr. Means?
As Dr. Casey Means continues her confirmation process, her nomination will be closely monitored, particularly regarding her responses to the concerns raised about her qualifications and the implications of her views on public health policies. The Senate's decision will ultimately determine her ability to lead the nation's public health initiatives amidst these controversies.
